Purchases and Sales Made in Q1 2023 in Acasti Pharma Inc. (ACST)
This table provides information about the institutional ownership of Acasti Pharma Inc. (ACST) during Q1 2023. The information is specifically focused on institutions that hold shares of Acasti Pharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2024
Q1 2023
|
Td Private Client Wealth LLC
New York, NY |
BUY
|
- |
241KNew |
$104K - $195K
|
241K
$780K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
90.8KNew |
$39K - $73.5K
|
90.8K
$294K
|
|
|
May 01, 2023
Q1 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
22.3KNew |
$9.57K - $18K
|
22.3K
$72.1K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
3.74KNew |
$1.61K - $3.03K
|
3.74K
$12.1K
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.8K+ 105.74% |
$776 - $1.46K
|
3.51K
$11.4K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.25KNew |
$538 - $1.01K
|
1.25K
$4.05K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|